John Collinge

33 Cleveland Street, W1W 7FF
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 179 publications

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Journal: Neurology

Published: July 13, 2026

A scalable, dividing cell model for the robust propagation and quantification of human sporadic Creutzfeldt-Jakob disease prions.

A scalable, dividing cell model for the robust propagation and quantification of human sporadic Creutzfeldt-Jakob disease prions.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 30, 2026

Strain-specific propagation of variant Creutzfeldt-Jakob disease prions in humanized neural cells.

Strain-specific propagation of variant Creutzfeldt-Jakob disease prions in humanized neural cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 11, 2026

Multidisciplinary recommendations for palliative and supportive care in Creutzfeldt-Jakob disease and related disorders.

Multidisciplinary recommendations for palliative and supportive care in Creutzfeldt-Jakob disease and related disorders.

Journal: Age and ageing

Published: April 13, 2026

Correction: Intracellular trafficking SNARE protein, syntaxin-6, modifies prion cellular phenotypes and risk of disease development in vivo.

Correction: Intracellular trafficking SNARE protein, syntaxin-6, modifies prion cellular phenotypes and risk of disease development in vivo.

Journal: Acta neuropathologica

Published: March 30, 2026

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure.

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure.

Journal: JAMA neurology

Published: March 30, 2026

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 13, 2026

Modification of early behavioural, physiological and neuropathological endpoints by syntaxin-6 knockout in a humanised P301S transgenic model of tauopathy.

Modification of early behavioural, physiological and neuropathological endpoints by syntaxin-6 knockout in a humanised P301S transgenic model of tauopathy.

Journal: Acta neuropathologica

Published: January 22, 2026

Letter to the Editor Regarding Kortazar-Zubizarreta et al. 'The Risk of Transmission of Genetic Prion Diseases Is Greater Than 50%'.

Letter to the Editor Regarding Kortazar-Zubizarreta et al. 'The Risk of Transmission of Genetic Prion Diseases Is Greater Than 50%'.

Journal: European journal of neurology

Published: January 18, 2026

Risk of transmission of amyloid β pathology via transfused blood products.

Risk of transmission of amyloid β pathology via transfused blood products.

Journal: Lancet (London, England)

Published: October 25, 2025

Intracellular trafficking SNARE protein, syntaxin-6, modifies prion cellular phenotypes and risk of disease development in vivo.

Intracellular trafficking SNARE protein, syntaxin-6, modifies prion cellular phenotypes and risk of disease development in vivo.

Journal: Acta neuropathologica

Published: August 02, 2025

Intracellular trafficking SNARE protein, syntaxin-6, modifies prion cellular phenotypes and risk of disease development in vivo.

Intracellular trafficking SNARE protein, syntaxin-6, modifies prion cellular phenotypes and risk of disease development in vivo.

Journal: Acta neuropathologica

Published: August 02, 2025

Showing 1-12 of 179

Last Updated: 09/26/2026